The University of Chicago Header Logo

Connection

Michael Davidson to Amides

This is a "connection" page, showing publications Michael Davidson has written about Amides.
Connection Strength

0.105
  1. Update on CETP inhibition. J Clin Lipidol. 2010 Sep-Oct; 4(5):394-8.
    View in: PubMed
    Score: 0.082
  2. Efficacy and safety of dalcetrapib in type 2 diabetes mellitus and/or metabolic syndrome patients, at high cardiovascular disease risk. Diabetes Obes Metab. 2012 Jan; 14(1):30-9.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.